rs149196489

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting

The NM_014679.5(CEP57):ā€‹c.422A>Gā€‹(p.Asn141Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000391 in 1,612,850 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N141H) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.00024 ( 0 hom., cov: 33)
Exomes š‘“: 0.00041 ( 1 hom. )

Consequence

CEP57
NM_014679.5 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 2.19
Variant links:
Genes affected
CEP57 (HGNC:30794): (centrosomal protein 57) This gene encodes a cytoplasmic protein called Translokin. This protein localizes to the centrosome and has a function in microtubular stabilization. The N-terminal half of this protein is required for its centrosome localization and for its multimerization, and the C-terminal half is required for nucleating, bundling and anchoring microtubules to the centrosomes. This protein specifically interacts with fibroblast growth factor 2 (FGF2), sorting nexin 6, Ran-binding protein M and the kinesins KIF3A and KIF3B, and thus mediates the nuclear translocation and mitogenic activity of the FGF2. It also interacts with cyclin D1 and controls nucleocytoplasmic distribution of the cyclin D1 in quiescent cells. This protein is crucial for maintaining correct chromosomal number during cell division. Mutations in this gene cause mosaic variegated aneuploidy syndrome, a rare autosomal recessive disorder. Multiple alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.053676963).
BS1
Variant frequency is greater than expected in population nfe. gnomad4_exome allele frequency = 0.000407 (594/1460610) while in subpopulation NFE AF= 0.000512 (569/1111868). AF 95% confidence interval is 0.000477. There are 1 homozygotes in gnomad4_exome. There are 296 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CEP57NM_014679.5 linkuse as main transcriptc.422A>G p.Asn141Ser missense_variant 4/11 ENST00000325542.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CEP57ENST00000325542.10 linkuse as main transcriptc.422A>G p.Asn141Ser missense_variant 4/111 NM_014679.5 Q86XR8-1

Frequencies

GnomAD3 genomes
AF:
0.000236
AC:
36
AN:
152240
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000441
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000176
AC:
44
AN:
250094
Hom.:
0
AF XY:
0.000163
AC XY:
22
AN XY:
135274
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000144
Gnomad NFE exome
AF:
0.000353
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000407
AC:
594
AN:
1460610
Hom.:
1
Cov.:
31
AF XY:
0.000407
AC XY:
296
AN XY:
726646
show subpopulations
Gnomad4 AFR exome
AF:
0.0000896
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000152
Gnomad4 NFE exome
AF:
0.000512
Gnomad4 OTH exome
AF:
0.000215
GnomAD4 genome
AF:
0.000236
AC:
36
AN:
152240
Hom.:
0
Cov.:
33
AF XY:
0.000148
AC XY:
11
AN XY:
74372
show subpopulations
Gnomad4 AFR
AF:
0.000121
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000441
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000379
Hom.:
0
Bravo
AF:
0.000257
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000115
AC:
14
EpiCase
AF:
0.000164
EpiControl
AF:
0.000178

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Mosaic variegated aneuploidy syndrome 2 Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 30, 2024This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 141 of the CEP57 protein (p.Asn141Ser). This variant is present in population databases (rs149196489, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with CEP57-related conditions. ClinVar contains an entry for this variant (Variation ID: 472257). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CEP57 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 24, 2023The c.422A>G (p.N141S) alteration is located in exon 4 (coding exon 4) of the CEP57 gene. This alteration results from a A to G substitution at nucleotide position 422, causing the asparagine (N) at amino acid position 141 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
14
DANN
Benign
0.30
DEOGEN2
Benign
0.011
T;.;T;.;T;.;.
Eigen
Benign
-0.34
Eigen_PC
Benign
-0.12
FATHMM_MKL
Benign
0.60
D
LIST_S2
Benign
0.80
T;T;T;T;T;T;T
M_CAP
Benign
0.061
D
MetaRNN
Benign
0.054
T;T;T;T;T;T;T
MetaSVM
Benign
-0.79
T
MutationAssessor
Benign
-0.73
.;N;N;.;.;N;.
MutationTaster
Benign
0.98
N;N;N;N;N
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
0.11
N;N;N;N;N;N;N
REVEL
Benign
0.036
Sift
Benign
0.45
T;T;T;T;T;T;T
Sift4G
Benign
0.77
T;T;T;T;T;T;T
Polyphen
0.020, 0.077, 0.063
.;B;B;.;.;B;.
Vest4
0.21
MVP
0.52
MPC
0.36
ClinPred
0.089
T
GERP RS
3.6
Varity_R
0.017
gMVP
0.047

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs149196489; hg19: chr11-95546671; API